Abstract: The present invention involves the localization of HER2 receptor (extra-cellular domain) in breast cancer cells, using a humanized monoclonal antibody. The invention is related to a modification of the Herceptin antibody, so as to maintain the antibody properties, while making the antibody directly recognizable in immunohistochemistry.
Type:
Application
Filed:
April 17, 2003
Publication date:
June 10, 2004
Applicant:
BIOTHER di Contardi Gabriella & C. Societa in accomandita semplice